Treatment of patients with deforming osteoarthrosis of joints
DOI:
https://doi.org/10.15674/0030-59872012484-89Keywords:
osteoarthrosis, artiflex, mucosatum, efficacy, toleranceAbstract
The article contains results of an open study aimed to assess the efficacy and tolerance of Artiflex Chondro drug versus Mucosat Neo, both based on chondroitin sulfate as their active substance. The study involved 112 patients, aged from 33 to 69, with deforming osteoarthrosis of the knee or hip joints at stages II-III by the Kellegren-Lawrence classification. The drugs were injected intramuscularly by 1.0 ml on alternate days thrice. Then the dose was enlarged up to 2.0 ml. The course of treatment consisted of 25 injections on alternate days. The therapeutic equivalence of the studied drugs was established. It was proved that Artiflex Chondro drug did not produce any negative effects on blood pressure, heart rate and body temperature. The indices of laboratory clinical and biochemical analyses of blood and urine in the end of the study did not change significantly versus their initial values. By its efficacy indices (pain syndrome intensity by the visual analogue scale, Lequesne index, time for walking 30 metres, demand for nonsteroidal anti-inflammatory drugs, Artiflex Chondro is an appropriate drug for treating patients with deforming osteoarthrosis. The drug does not produce any adverse reactions and can be recommended as a chondroprotective remedy.
References
- Коршунов Н. И. Современные подходы к фармакотерапии остеоартроза / Н. И. Коршунов, О. Б. Ершова // CONSILIUM MEDICUM. — 2006. — № 2. — С. 34–38.
- Корж Н. А. Остеоартроз. Консервативная терапия / Под ред. Н. А. Коржа, Н. В. Дедух, И. А. Зупанца. — Харьков: «Золотые страницы», 2007 — 423 с.
- Поворознюк В. В. Глюкозамин и хондроитин в лечении остеоартроза: данные литературы и результаты собственных исследований / В. В. Поворознюк // РМЖ. — 2006. — Т. 14, № 4. — С. 290–294.
- Серов В. В. Соединительная ткань / В. В. Серов, А. Б. Шехтер — М.: Медицина, 1981 — 312 с.
- EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) / K. M. Jordan, N. K. Arden, M. Doherty et al. // Ann. Rheum. Dis. — 2003. — Vol. 62 (12). — P. 1145–1155.
- Leeb B. F. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis / B. F. Leeb, H. Schweitzer, K. Montag // J. Reumatol. — 2000. — Vol. 27. — P. 205–211.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2014 Volodymyr Filipenko, Frieda Leontyeva, Olga Podgayskaya
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.
Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.
The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).
